Patents by Inventor Hilmar Lemke

Hilmar Lemke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-CD30 antibodies preventing proteolytic cleavage and release of membrane-bound CD30 antigen
    Patent number: 6033876
    Abstract: An antibody which binds to the CD30 antigen and a) inhibits the release of sCD30 from Hodgkin's disease cells, and b) does not bind to B cell non-Hodgkin's lymphomas or plasma cells. An example of such antibodies are the antibodies secreted from hybridoma cell line DSM ACC 2204. The antibodies may be used for diagnosis, or conjugated to a toxin to produce an immunotoxin.
    Type: Grant
    Filed: September 26, 1997
    Date of Patent: March 7, 2000
    Assignee: Boehringer Mannheim GmbH
    Inventors: Hilmar Lemke, Hinrich-Peter Hansen